Updated results of fruquintinib combined with PD-1 inhibitors and chemotherapy in the first-line treatment of HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma (FDZL-FIX): a ...

Data will be shared in two oral presentations, a poster and two online abstracts ; Highlights include a potential novel, all-oral therapy for AML; and Phase ...